SITUS JUDI MBL77 - AN OVERVIEW

Not all patients with CLL demand therapy. Despite all modern advances, the iwCLL nevertheless endorses watchful observation for patients with asymptomatic disorder.86 This suggestion relies on at the least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The